Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 2 , Pages 193-212 , June 2009

Relevance of non-albumin colloids in intensive care medicine

References 

  1. Schadt JC, Ludbrook J. Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. The American Journal of Physiology. 1991;260:H305–H318
  2. Vincent JL, Weil MH. Fluid challenge revisited. Critical Care Medicine. 2006;34:1333–1337
  3. Hinder F, Stubbe HD, Van Aken H, et al. Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor-masked hypovolemia. Critical Care Medicine. 2003;31:903–909
  4. Moller AM, Pedersen T, Svendsen PE, Engquist A. Perioperative risk factors in elective pneumonectomy: the impact of excess fluid balance. European Journal of Anaesthesiology. 2002;19:57–62
  5. Schuller D, Mitchell JP, Calandrino FS, Schuster DP. Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome?. Chest. 1991;100:1068–1075
  6. Simmons RS, Berdine GG, Seidenfeld JJ, et al. Fluid balance and the adult respiratory distress syndrome. The American Review of Respiratory Disease. 1987;135:924–929
  7. Rehm M, Haller M, Orth V, et al. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology. 2001;95:849–856
  8. Rehm M, Zahler S, Lotsch M, et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology. 2004;100:1211–1223
  9. Lang K, Boldt J, Suttner S, Haisch G. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesthesia and Analgesia. 2001;93:405–409
  10. Boldt J, Ducke M, Kumle B, et al. Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery. Intensive Care Medicine. 2004;30:416–422
  11. Boldt J. Pro: use of colloids in cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia. 2007;21:453–456
  12. Chalidis B, Kanakaris N, Giannoudis PV. Safety and efficacy of albumin administration in trauma. Expert Opinion on Drug Safety. 2007;6:407–415
  13. Wong F. Drug insight: the role of albumin in the management of chronic liver disease. Nature Clinical Practice. Gastroenterology & Hepatology. 2007;4:43–51
  14. Liberati A, Moja L, Moschetti I, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Internal and Emergency Medicine. 2006;1:243–245
  15. Mendez CM, McClain CJ, Marsano LS. Albumin therapy in clinical practice. Nutrition in Clinical Practice. 2005;20:314–320
  16. Alderson P, Bunn F, Lefebvre C, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database of Systematic Reviews (Online). 2004;4:CD001208
  17. Bayliss WM. Intravenous injection in wound shock. British Medical Journal. 1918;1:553
  18. Le Gal YM. A review of the history of blood replacement from the 17th to the 20th centuries. Review of Surgery. 1975;32:229–239
  19. Hogan JJ. The intravenous use of colloidal (gelatin) solutions in shock. The Journal of the American Medical Association. 1915;64:721
  20. Hecht G, Weese H. Periston, ein neuer Blutflüssigkeitsersatz. MMW, Münchener Medizinische Wochenschrift. 1943;90:11
  21. Wesse H, Scholtan W. Pharmacology of periston N. Deutsche Medizinische Wochenschrift (1946). 1951;76:1492–1493
  22. Grönwall A, Ingelman B. Untersuchungen über Dextran und sein Verhalten bei parenteraler Zufuhr. I. Chemische und physikalisch-chemische Untersuchungen über Dextran. Acta Physiologica Scandinavica. 1944;7:97–107
  23. Aktories K. General and specific pharmacology and toxicology. 9th edn.. Munich: Elsevier, Urban & Fischer; 2006;
  24. Koekenberg LJ. Experimental use of macrodex as a prophylaxis against post-operative thrombo-embolism. Bulletin de la Société Internationale de Chirurgie. 1962;21:501–512
  25. Gruber UF. Prevention of fatal postoperative pulmonary embolism by heparin dihydroergotamine or dextran 70. The British Journal of Surgery. 1982;69(Suppl.):S54–S58
  26. Gruber UF, Saldeen T, Brokop T, et al. Incidences of fatal postoperative pulmonary embolism after prophylaxis with dextran 70 and low-dose heparin: an international multicentre study. British Medical Journal. 1980;280:69–72
  27. Hohl MK, Luscher KP, Tichy J, et al. Prevention of postoperative thromboembolism by dextran 70 or low-dose heparin. Obstetrics and Gynecology. 1980;55:497–500
  28. Kamler M, Pizanis N, Hagl S, et al. Extracorporal-circulation-induced leukocyte/endothelial cell interaction is inhibited by dextran. Clinical Hemorheology and Microcirculation. 2004;31:139–148
  29. Ljungstrom KG. The antithrombotic efficacy of dextran. Acta Chirurgica Scandinavica. Supplementum. 1988;543:26–30
  30. Bronwell AW, Artz CP, Sako Y. Evaluation of blood loss from a standardized wound after dextran. Surgical Forum. 1955;5:809–814
  31. Kruger K, Seifart W, Freudenberg R. Infusion incidents with dextran. Acta Anaesthesiologica. 1988;13:259–271
  32. Schortgen F, Girou E, Deye N, Brochard L. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Medicine. 2008;34:2157–2168
  33. Godwin G. Dextrans and compatibility testing. Transfusion. 1987;27:366–367
  34. Schortgen F, Deye N, Brochard L. Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Medicine. 2004;30:2222–2229
  35. Hussain SF, Drew PJ. Acute renal failure after infusion of gelatins. British Medical Journal. 1989;299:1137–1138
  36. Wiedersheim M. An investigation of oxyethylstarch as a new plasma volume expander in animals. Archives Internationales de Pharmacodynamie et de Thérapie. 1957;111:353–361
  37. Mishler JM. Pharmacology of hydroxyethyl starch – use in therapy and blood banking. New York, Toronto: Oxford University Press; 1982;
  38. Food and Drug Administration . FDA approves voluven to treat serious blood volume loss following surgery. Available from: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01765.html
  39. Hoffmann JN, Vollmar B, Laschke MW, et al. Hydroxyethyl starch (130kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology. 2002;97:460–470
  40. Singh N, Singh S, Kaur L, et al. Morphological, thermal and rheological properties of starches from different botanical sources. Food Chemistry. 2003;81:219–231
  41. Sommermeyer R, Cech F, Schossow R. Differences in chemical structures between waxy maize- and potato-starch-based hydroxyethyl starch volume therapeutics. Transfusion Alternatives in Transfusion Medicine. 2007;9:127–133
  42. Godet MC, Tran V, Colonna P, Buleon A. Inclusion/exclusion of fatty acids in amylose complexes as a function of the fatty acid chain length. International Journal of Biological Macromolecules. 1995;17:405–408
  43. Szejtli J, Bánky-Elöd I. Determination of dissociation-constants of amylose clathrates. Stärke. 1978;30:85–91
  44. Jungheinrich C, Scharpf R, Wargenau M, et al. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500mL) in mild-to-severe renal impairment. Anesthesia and Analgesia. 2002;95:544–551
  45. Yacobi A, Stoll RG, Sum CY, et al. Pharmacokinetics of hydroxyethyl starch in normal subjects. Journal of Clinical Pharmacology. 1982;22:206–212
  46. Treib J, Haass A, Pindur G, et al. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics. Thrombosis and Haemostasis. 1995;74:1452–1456
  47. Treib J, Haass A, Pindur G, et al. Influence of intravascular molecular weight of hydroxyethyl starch on platelets. European Journal of Haematology. 1996;56:168–172
  48. Neff TA, Doelberg M, Jungheinrich C, et al. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesthesia and Analgesia. 2003;96:1453–1459
  49. Stander S, Szepfalusi Z, Bohle B, et al. Differential storage of hydroxyethyl starch (HES) in the skin: an immunoelectron-microscopical long-term study. Cell and Tissue Research. 2001;304:261–269
  50. Waitzinger J, Bepperling F, Pabst G, Opitz J. Hydroxyethyl starch (HES) [130/0.4], a new HES specification: pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers. Drugs in R&D. 2003;4:149–157
  51. Sirtl C, Laubenthal H, Zumtobel V, et al. Tissue deposits of hydroxyethyl starch (HES): dose-dependent and time-related. British Journal of Anaesthesia. 1999;82:510–515
  52. Murphy M, Carmichael AJ, Lawler PG, et al. The incidence of hydroxyethyl starch-associated pruritus. The British Journal of Dermatology. 2001;144:973–976
  53. Klemm E, Bepperling F, Burschka MA, Mosges R. Hemodilution therapy with hydroxyethyl starch solution (130/0.4) in unilateral idiopathic sudden sensorineural hearing loss: a dose-finding, double-blind, placebo-controlled, international multicenter trial with 210 patients. Otology & Neurotology. 2007;28:157–170
  54. Rudolf J. Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo-controlled phase II safety study. Cerebrovascular Diseases (Basel, Switzerland). 2002;14:33–41
  55. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1:466–469
  56. Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Annales Françaises D’anesthèsie et de Rèanimation. 1994;13:301–310
  57. Davidson IJ. Renal impact of fluid management with colloids: a comparative review. European Journal of Anaesthesiology. 2006;23:721–738
  58. Boldt J, Priebe HJ. Intravascular volume replacement therapy with synthetic colloids: is there an influence on renal function?. Anesthesia and Analgesia. 2003;96:376–382
  59. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001;357:911–916
  60. Boldt J, Brenner T, Lehmann A, et al. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin. Intensive Care Medicine. 2003;29:763–769
  61. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. The New England Journal of Medicine. 2008;358:125–139
  62. Moran M, Kapsner C. Acute renal failure associated with elevated plasma oncotic pressure. The New England Journal of Medicine. 1987;317:150–153
  63. Boldt J. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis. Lancet. 2001;358:581–583
  64. Thomas G, Balk EM, Jaber BL. Effect of intensive insulin therapy and pentastarch resuscitation on acute kidney injury in severe sepsis. American Journal of Kidney Diseases. 2008;52:13–17
  65. Matheson NA, Diomi P. Renal failure after the administration of dextran 40. Surgery, Gynecology & Obstetrics. 1970;131:661–668
  66. Mailloux L, Swartz CD, Capizzi R, et al. Acute renal failure after administration of low-molecular weight dextran. The New England Journal of Medicine. 1967;277:1113–1118
  67. Morgan T, Little JM. Renal failure and low-molecular-weight dextran. British Medical Journal. 1967;1:635
  68. Vogt N, Brinkmann A, Georgieff M. The effect of HES, dextran and gelatin on kidney function. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie. 1998;33:268–270
  69. Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. American Journal of Kidney Diseases. 2008;51:491–503
  70. Legendre C, Thervet E, Page B, et al. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet. 1993;342:248–249
  71. Eisenbach C, Schonfeld AH, Vogt N, et al. Pharmacodynamics and organ storage of hydroxyethyl starch in acute hemodilution in pigs: influence of molecular weight and degree of substitution. Intensive Care Medicine. 2007;33:1637–1644
  72. Vogt NH, Bothner U, Lerch G, et al. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Anesthesia and Analgesia. 1996;83:262–268
  73. Sakr Y, Payen D, Reinhart K, et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. British Journal of Anaesthesia. 2007;98:216–224
  74. Ertmer C, Pinto BB, Rehberg S, et al. Incidence of renal replacement therapy in intensive care patients treated with different hydroxyethyl starch solutions. Intensive Care Medicine. 2008;34(Suppl. 1):S196
  75. Boldt J, Brosch C, Rohm K, et al. Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients. British Journal of Anaesthesia. 2008;100:457–464
  76. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews (Online). 2007;4:CD000567
  77. Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database of Systematic Reviews (Online). 2008;1:CD001319
  78. Karanko MS. Effects of three colloid solutions on plasma volume and hemodynamics after coronary bypass surgery. Critical Care Medicine. 1987;15:1015–1022
  79. Tollofsrud S, Svennevig JL, Breivik H, et al. Fluid balance and pulmonary functions during and after coronary artery bypass surgery: Ringer's acetate compared with dextran, polygeline, or albumin. Acta Anaesthesiologica Scandinavica. 1995;39:671–677
  80. Hiippala S, Linko K, Myllyla G, et al. Replacement of major surgical blood loss by hypo-oncotic or conventional plasma substitutes. Acta Anaesthesiologica Scandinavica. 1995;39:228–235
  81. Charlet P, Zerr C, Robert D, et al. Comparative trials of fluid gelatins on hemostasis in heart surgery in adults. Cahiers D’anesthésiologie. 1991;39:233–238
  82. Beards SC, Watt T, Edwards JD, et al. Comparison of the hemodynamic and oxygen transport responses to modified fluid gelatin and hetastarch in critically ill patients: a prospective, randomized trial. Critical Care Medicine. 1994;22:600–605
  83. Boldt J, Knothe C, Zickmann B, et al. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesthesia and Analgesia. 1993;76:1185–1190
  84. Asfar P, Kerkeni N, Labadie F, et al. Assessment of hemodynamic and gastric mucosal acidosis with modified fluid versus 6% hydroxyethyl starch: a prospective, randomized study. Intensive Care Medicine. 2000;26:1282–1287
  85. Molnar Z, Mikor A, Leiner T, Szakmany T. Fluid resuscitation with colloids of different molecular weight in septic shock. Intensive Care Medicine. 2004;30:1356–1360
  86. Allison KP, Gosling P, Jones S, et al. Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation. The Journal of Trauma. 1999;47:1114–1121
  87. Beyer R, Harmening U, Rittmeyer O, et al. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. British Journal of Anaesthesia. 1997;78:44–50
  88. Huttner I, Boldt J, Haisch G, et al. Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery. British Journal of Anaesthesia. 2000;85:417–423
  89. Kumle B, Boldt J, Piper S, et al. The influence of different intravascular volume replacement regimens on renal function in the elderly. Anesthesia and Analgesia. 1999;89:1124–1130
  90. Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, Kuitunen AH. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesthesia and Analgesia. 2006;102:998–1006
  91. Van der Linden PJ, De Hert SG, Daper A, et al. 3.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Canadian Journal of Anaesthesia. 2004;51:236–241
  92. Verheij J, van Lingen A, Raijmakers PG, et al. Effect of fluid loading with saline or colloids on pulmonary permeability, oedema and lung injury score after cardiac and major vascular surgery. British Journal of Anaesthesia. 2006;96:21–30
  93. Haisch G, Boldt J, Krebs C, et al. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. Journal of Cardiothoracic and Vascular Anesthesia. 2001;15:316–321
  94. Haisch G, Boldt J, Krebs C, et al. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesthesia and Analgesia. 2001;92:565–571
  95. Van der Linden PJ, De Hert SG, Deraedt D, et al. Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs. Anesthesia and Analgesia. 2005;101:629–634
  96. Boldt J, Zickmann B, Rapin J, et al. Influence of volume replacement with different HES-solutions on microcirculatory blood flow in cardiac surgery. Acta Anaesthesiologica Scandinavica. 1994;38:432–438
  97. Gan TJ, Bennett-Guerrero E, Phillips-Bute B, et al. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend study group. Anesthesia and Analgesia. 1999;88:992–998
  98. Boldt J, Haisch G, Suttner S, et al. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. British Journal of Anaesthesia. 2002;89:722–728
  99. Langeron O, Doelberg M, Ang ET, et al. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesthesia and Analgesia. 2001;92:855–862
  100. Gallandat Huet RC, Siemons AW, Baus D, et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Canadian Journal of Anaesthesia. 2000;47:1207–1215
  101. Boldt J, Lehmann A, Rompert R, et al. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia. 2000;14:264–268
  102. Boldt J, Schollhorn T, Munchbach J, Pabsdorf M. A total balanced volume replacement strategy using a new balanced hydoxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery. European Journal of Anaesthesiology. 2007;24:267–275
  103. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesthesia and Analgesia. 2008;107:382–390
  104. Boldt J, Brosch C, Ducke M, et al. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin. Critical Care Medicine. 2007;35:2740–2746
  105. Wilkes NJ, Woolf RL, Powanda MC, et al. Hydroxyethyl starch in balanced electrolyte solution (Hextend) – pharmacokinetic and pharmacodynamic profiles in healthy volunteers. Anesthesia and Analgesia. 2002;94:538–544
  106. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clinical Pharmacokinetics. 2005;44:681–699
  107. Boldt J. Volume therapy in cardiac surgery: does the kind of fluid matter?. Journal of Cardiothoracic and Vascular Anesthesia. 1999;13:752–763
  108. Boldt J. Volume replacement therapy. Stuttgart: Georg Thieme; 2001;
  109. Tonnessen T, Tollofsrud S, Kongsgaard UE, Noddeland H. Colloid osmotic pressure of plasma replacement fluids. Acta Anaesthesiologica Scandinavica. 1993;37:424–426

PII: S1521-6896(08)00098-0

doi: 10.1016/j.bpa.2008.11.001

Best Practice & Research Clinical Anaesthesiology
Volume 23, Issue 2 , Pages 193-212 , June 2009

Article Tools

* Image Usage & Resolution